{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-190491","form_type":"8-K","ticker":"IBRX","cik":"0001326110","company_name":"ImmunityBio, Inc.","filed_at":"2023-07-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.579462+00:00","generated_at":"2026-06-13T05:28:10.681989+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ImmunityBio updates Sorrento settlement terms; securities class action filed","bullets":["Sorrento settlement hearing set for Aug 14, 2023; two scenarios: pay judgments by Aug 31 or release claims and relinquish NANTibody interests.","If settlement not approved, ImmunityBio will continue pursuing judgment collection; no receivables recorded as of June 30, 2023.","Securities class action filed June 30, 2023 in S.D. Cal. alleging false statements re FDA complete response letter for Anktiva (N-803).","Company believes class action is without merit and intends to defend vigorously; cannot estimate potential loss.","FDA CRL cited deficiencies at third-party contract manufacturers; BLA for N-803 + BCG for bladder cancer not approved."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-190491","json":"https://secwatch.observer/filing/0001193125-23-190491.json","markdown":"https://secwatch.observer/filing/0001193125-23-190491.md","text":"https://secwatch.observer/filing/0001193125-23-190491.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326110/000119312523190491/0001193125-23-190491-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326110/000119312523190491/d473206d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T05:28:10.681989+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}